Clinical Trials on Venous Thrombosis (Disorder) in Switzerland

Total 2661 results

University of Zurich
JH Rahn Foundation, Zurich

Completed

Practicability of Gliding Aids for Medical Compression Stockings

Chronic Venous Insufficiency | Post-thrombotic Syndrome

Switzerland
University of Zurich
Medical University of Vienna; RWTH Aachen University; University Hospital Heidelberg and other collaborators

Terminated

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS (ARIVA)

Stent Stenosis | Venous Thromboses

Austria, Germany, Switzerland
University of Zurich

Completed

Bern Venous Stent Registry

Post-thrombotic Syndrome

Switzerland
University Hospital Inselspital, Berne
University Hospital, Geneva; Centre Hospitalier Universitaire Vaudois; University...

Completed

Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients (RISE)

Embolism and Thrombosis | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Mobility Limitation | Hospital Acquired Condition | Venous Thromboses

Switzerland
Inari Medical

Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis (DEFIANCE)

Venous Thromboembolism | Deep Venous Thrombosis | Post-Thrombotic Syndrome

United States, Germany, Finland, Switzerland, United Kingdom
University Hospital Inselspital, Berne
Schweizerische Herzstiftung

Completed

The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)

Cerebral Venous Thrombosis

Switzerland, Netherlands
Jan Stam, MD, PhD
Dutch Heart Foundation

Terminated

Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT)

Sinus Thrombosis, Intracranial

Netherlands, France, China, Portugal, Canada, Switzerland
University Hospital Inselspital, Berne

Completed

Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis (BERNUTIFUL)

Venous Thrombosis | Postthrombotic Syndrome

Switzerland
Marc Righini
The Ottawa Hospital; University Hospital, Brest

Unknown

Left Rule, D-Dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy.

Pregnancy | Deep Vein Thrombosis

Switzerland
University Hospital, Brest
Ministry of Health, France

Completed

Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and Postpartum (EDVIGE)

Deep Vein Thrombosis

France, Switzerland
Optimed Medizinische Instrumente GmbH

Completed

Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study

Post-thrombotic Syndrome | Iliac Vein Compression Syndrome

Switzerland, Austria, Germany, Netherlands
University Hospital, Basel, Switzerland

Completed

Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy (RITE)

Venous Thrombosis | Bleeding | Varicose Veins | Thromboembolism

Switzerland
Bayer
Janssen Research & Development, LLC

Completed

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA)

Venous Thrombosis | Deep Vein Thrombosis

Switzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
University of Zurich
Life Molecular Imaging SA

Terminated

Evaluation of a New Imagingtechnologie for Thrombosis (PET-GP1_1)

Deep Vein Thrombosis | Abdominal Aortic Aneurysm

Switzerland
University Hospital Inselspital, Berne

Terminated

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Age-related Macular Degeneration | Macular Edema | Retinal Vein Occlusion | Central Serous Chorioretinopathy | Retinal Neovascularization

Switzerland
University Hospital, Geneva

Completed

Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial (PP-HEP)

Venous Thromboembolism

Switzerland
University Hospital Inselspital, Berne

Completed

Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients

Venous Thromboembolism

Switzerland
University of Zurich

Completed

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Venous Thromboembolism

Switzerland
University Hospital Inselspital, Berne
Bayer; Centre Hospitalier Universitaire Vaudois

Completed

Rivaroxaban in Bariatric Surgery

Prophylaxis of Venous Thromboembolism

Switzerland
University Hospital, Geneva
Canadian Institutes of Health Research (CIHR); Ministry of Health, France; Swiss... and other collaborators

Completed

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT) (CACTUS-PTS)

Distal (Calf) Deep-vein Thrombosis

Canada, Switzerland, France
University Hospital, Basel, Switzerland

Terminated

Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis

Thrombosis

Switzerland
University Hospital, Geneva

Completed

Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives (PILL-OFF)

Contraception | Venous Thromboembolism

Switzerland
University Hospital Inselspital, Berne
University of Lausanne Hospitals

Completed

PK of Rivaroxaban in Bariatric Patients - Extension

Prophylaxis of Venous Thromboembolism

Switzerland
Marc Blondon

Recruiting

Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study (TPX-ENHANCE)

Venous Thromboembolism

Switzerland
Bayer
Janssen Research & Development, LLC

Completed

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis (EINSTEINJr)

Venous Thromboembolism

Switzerland, Spain, United States, Austria, Italy, Russian Federation, United Kingdom, Brazil, Australia, Canada, Hungary, Netherlands, Israel, Poland, Japan
Ottawa Hospital Research Institute
University Hospital, Geneva; Leiden University Medical Center

Unknown

Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer (LEaD)

Pregnancy | Deep Vein Thrombosis

Netherlands, Canada, Switzerland, United States
Insel Gruppe AG, University Hospital Bern
Bayer; Janssen Pharmaceuticals

Completed

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery (BARIVA)

Bariatric Surgery

Switzerland
University of Iceland
Medical University of Vienna; University Hospital, Basel, Switzerland; University... and other collaborators

Completed

Study of Retinal Oxygenation in Central Retinal Vein Occlusion

Retinal Vein Occlusion

Austria, Czechia, Denmark, Germany, Iceland, Switzerland, United Kingdom
University Hospital, Geneva
Swiss National Science Foundation; University Hospital, Brest

Completed

Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study

Deep Vein Thrombosis | Pulmonary Embolism

France, Switzerland
University Hospital, Geneva
University Medical Center Groningen; The Ottawa Hospital

Unknown

Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study (ADJUST-DVT)

Deep Vein Thrombosis | D-dimer

Canada, Switzerland, France
Marc Blondon

Completed

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study (PREFER-PP)

Pregnancy Related | Venous Thromboembolism

France, Switzerland
University Hospital, Geneva

Terminated

Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

Cancer | Venous Thromboembolism

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

Switzerland
Ottawa Hospital Research Institute

Completed

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (PREDICTORS)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboembolic Disease Recurrent | Recurrent Thromboembolic Disease

Canada, Netherlands, Switzerland
University Medical Center Groningen

Completed

Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis (Armour)

Suspected Upper Extremity Deep Vein Thrombosis

Austria, Netherlands, Italy, Belgium, Switzerland, Germany, United States
University Hospital, Geneva
Sanofi; University of Zurich; University Hospital Inselspital, Berne; Luzerner... and other collaborators

Completed

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

Venous Thromboembolism

Switzerland
GlaxoSmithKline

Completed

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Thrombosis, Venous

Netherlands, Spain, Germany, Italy, Poland, Russian Federation, France, Israel, Estonia, Hungary, Slovakia, Latvia, Greece, Ukraine, Czech Republic, Switzerland, Bulgaria
University of Lausanne Hospitals

Completed

The Swiss Venous Thromboembolism Cohort 65+ (SWITCO65+)

Venous Thromboembolism

Switzerland
Bayer
Janssen Research & Development, LLC

Completed

Oral Rivaroxaban in Children With Venous Thrombosis (EINSTEINJunior)

Venous Thrombosis

France, United States, Switzerland, Netherlands, Canada, Germany, Austria, Australia, Israel, Italy
Boehringer Ingelheim

Completed

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Venous Thromboembolism

Italy, Thailand, Russian Federation, Canada, Lithuania, Switzerland
Bayer
Janssen Research & Development, LLC

Completed

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Venous Thrombosis | Pediatrics

Italy, United States, Austria, Australia, Canada, France, Switzerland, Germany, Israel, Ireland
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Japan, Canada, Ireland, Italy, Korea, Republic of, France, Switzerland, Hungary, Netherlands, Latvia, Germany, Norway, Sweden, Czechia, United Kingdom
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Latvia, Ireland, Germany, United Kingdom, Canada, Norway, Sweden, Czechia, Switzerland
University Hospital, Geneva

Completed

Hemostatic Profiles of Endocrine Therapies for Breast Cancer (HEMOBREAST)

Breast Neoplasms | Venous Thromboembolism

Switzerland
University of Zurich
University Hospital, Geneva; University Hospital Inselspital, Berne; University... and other collaborators

Terminated

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

COVID-19 | Pulmonary Embolism, Deep Vein Thrombosis

Switzerland, Germany
Ottawa Hospital Research Institute
BioMérieux; Centre Hospitalier Régional et Universitaire de Brest

Completed

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism (REVERSEII)

Idiopathic Venous Thromboembolism

United States, Canada, Australia, Belgium, France, India, Switzerland
Bayer

Completed

Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Venous Thrombosis | Deep Vein Thrombosis

Belgium, Israel, Italy, Spain, Switzerland, Colombia, New Zealand, Hungary, Canada, Sweden, Austria, Czechia, Germany, Poland, Netherlands, Peru, South Africa, Australia, Brazil
Daiichi Sankyo, Inc.

Completed

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

France, United States, Japan, Denmark, Italy, Russian Federation, Czechia, Germany, India, Israel, Philippines, Taiwan, Ukraine, Australia, Austria, China, Argentina, Belarus, Belgium, Brazil, Canada, Chile, Estonia, Hungary, Korea, Republic... and more
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
Bayer
Janssen Research & Development, LLC

Completed

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty (XAMOS)

Venous Thromboembolism

Switzerland, China, Slovakia, France, Germany, Hungary, Korea, Republic of, Singapore, South Africa, Spain, Sweden, Philippines, Australia, Austria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Latvia, Lebanon, Lithuania, Macedonia... and more

Clinical Trials on Venous Thrombosis (Disorder) in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations